Oppenheimer Asset Management Inc. Purchases 4,350 Shares of Danaher Corporation $DHR

Oppenheimer Asset Management Inc. raised its holdings in Danaher Corporation (NYSE:DHR) by 2.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 163,134 shares of the conglomerate’s stock after buying an additional 4,350 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Danaher were worth $32,343,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. WFA of San Diego LLC bought a new stake in Danaher in the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher during the second quarter valued at approximately $27,000. TruNorth Capital Management LLC acquired a new position in shares of Danaher during the third quarter worth approximately $28,000. Tripletail Wealth Management LLC bought a new position in shares of Danaher in the 3rd quarter worth $31,000. Finally, Heartwood Wealth Advisors LLC acquired a new stake in Danaher in the 3rd quarter valued at $37,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on DHR. Guggenheim lifted their price target on Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a research note on Friday, January 2nd. JPMorgan Chase & Co. lifted their target price on Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, January 29th. Robert W. Baird set a $251.00 price target on Danaher in a report on Thursday, January 29th. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. Finally, Jefferies Financial Group upped their target price on shares of Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Twenty equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $253.86.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 21,776 shares of the stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the sale, the senior vice president owned 14,553 shares in the company, valued at approximately $3,190,454.19. This trade represents a 59.94% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Teri List sold 3,298 shares of the business’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director owned 20,762 shares in the company, valued at $4,702,593. This represents a 13.71% decrease in their position. The SEC filing for this sale provides additional information. 11.20% of the stock is owned by insiders.

Danaher Stock Up 0.5%

Shares of NYSE DHR opened at $216.77 on Monday. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The company has a market cap of $153.12 billion, a P/E ratio of 43.01, a P/E/G ratio of 2.93 and a beta of 0.91. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80. The business has a 50-day simple moving average of $229.62 and a two-hundred day simple moving average of $215.17.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 28th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm posted $2.14 EPS. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. Research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio (DPR) is presently 25.40%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.